Literature DB >> 2746584

Protective HLA-DR phenotypes in rheumatoid arthritis.

B A Larsen1, C A Alderdice, D Hawkins, J R Martin, D M Mitchell, D P Sheridan.   

Abstract

In a study of HLA-DR phenotypes in patients with rheumatoid arthritis (RA) and controls from the Saskatoon area and in Newfoundland, we found that certain phenotypes occurred more frequently in the patients than in healthy controls in both populations ("increased risk phenotypes"). The reverse was also true: certain phenotypes were reduced or excluded from patients with RA compared with controls. Three increased risk phenotypes with twice the expected frequencies or more were HLA-DR1,DR4; DR4 and DR4,DR5. Four "protective" phenotypes with half or less the expected frequencies were HLA-DR1, DR5; DR2; DR2,DR3 and DR3,DR7. We speculate that at least for the DR3,DR7 phenotype, the protective effect may be due to a hybrid DQw2 molecule.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2746584

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  3 in total

1.  The HLA-DRB1 shared epitope in Caucasians with rheumatoid arthritis: a lesson learned from tic-tac-toe.

Authors:  S Louis Bridges; James M Kelley; Laura B Hughes
Journal:  Arthritis Rheum       Date:  2008-05

2.  Frequency of HLA-DRB1 alleles in rheumatoid arthritis patients in Zahedan, southeast Iran.

Authors:  Mahnaz Sandoughi; Asghar Fazaeli; Gholamreza Bardestani; Mohammad Hashemi
Journal:  Ann Saudi Med       Date:  2011 Mar-Apr       Impact factor: 1.526

3.  A new classification of HLA-DRB1 alleles based on acid-base properties of the amino acids located at positions 13, 70 and 71: impact on ACPA status or structural progression, and meta-analysis on 1235 patients with rheumatoid from two cohorts (ESPOIR and EAC cohort).

Authors:  Adeline Ruyssen-Witrand; Hanna W van Steenbergen; Jurgen van Heemst; Pierre-Antoine Gourraud; Delphine Nigon; Cédric Lukas; Corinne Miceli-Richard; Bénédicte Jamard; Anne Cambon-Thomsen; Alain Cantagrel; Philippe Dieudé; Annette H M van der Helm-van Mil; Arnaud Constantin
Journal:  RMD Open       Date:  2015-11-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.